Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

3.6%

1 terminated/withdrawn out of 28 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

39%

11 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

11 recruiting3 with results

Enrollment Performance

Analytics

Phase 3
9(36.0%)
Phase 1
6(24.0%)
Phase 2
5(20.0%)
N/A
3(12.0%)
Phase 4
2(8.0%)
25Total
Phase 3(9)
Phase 1(6)
Phase 2(5)
N/A(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT05438407Phase 3Active Not Recruiting

Pediatric Patients Aged 4 to 11 Years With APDS

Role: collaborator

NCT07219238Phase 2Recruiting

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Role: collaborator

NCT06916806Phase 1Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Role: collaborator

NCT06706817Phase 3Recruiting

A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

Role: collaborator

NCT06651970Phase 4Recruiting

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Role: collaborator

NCT07093398Phase 1Completed

A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants

Role: collaborator

NCT07017933Not ApplicableRecruiting

Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes

Role: collaborator

NCT06473779Phase 3Active Not Recruiting

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

Role: collaborator

NCT06398730Phase 1Completed

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Role: collaborator

NCT06713369Phase 1Recruiting

AZD5305 hADME in Patients With Advanced Solid Malignancies

Role: collaborator

NCT07109219Phase 1Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Role: collaborator

NCT06563102Phase 4Completed

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

Role: collaborator

NCT06692764Phase 2Completed

A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Role: collaborator

NCT06933472Phase 3Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Role: collaborator

NCT06083012Active Not Recruiting

Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

Role: collaborator

NCT07244705Phase 1Recruiting

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Role: collaborator

NCT05693129Phase 3Active Not Recruiting

Pediatric Patients Aged 1 to 6 Years With APDS

Role: collaborator

NCT04702451Not ApplicableCompleted

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Role: collaborator

NCT06398743Active Not Recruiting

First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

Role: collaborator

NCT05636852Phase 2Terminated

Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Role: collaborator